PROKProKidney Corp.
What is the market doing?
In a downtrend (−12% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In a downtrend, below its 50- and 200-day averages. Price is −12% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PROK is trading
ProKidney Corp. is −44% over the past year while the S&P 500 is +18%: 62 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −12%
vs 200-day average · a clear downtrend
- RSI (14)
- 34
RSI (14) · neutral
- Below its 52-week high
- 49%
Below its 52-week high
Details›
- Last close2026-10-08
- $1.67
- 1 monthS&P 500 +1.6%
- −10%
- 1 yearS&P 500 +18%
- −44%
- 5 yearsS&P 500 +86%
- −83%
- vs 50-day average$1.69
- −1.0%
- 52-week high
- $3.30
- 52-week low
- $1.33
- Annualised volatility
- 377%
| Year | Return |
|---|---|
| 2026 (year to date) | −25% |
| 2025 | +33% |
| 2024 | −5.1% |
| 2023 | −74% |
| 2022 | −31% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 1 of 5 | +2.2% |
| Feb | 5 | 4 of 5 | +4.9% |
| Mar | 5 | 2 of 5 | −10% |
| Apr | 5 | 3 of 5 | +3.3% |
| May | 5 | 3 of 5 | +15% |
| Jun | 5 | 2 of 5 | −8.8% |
| Jul | 6 | 2 of 6 | +58% |
| Aug | 6 | 2 of 6 | −4.3% |
| Sep | 6 | 2 of 6 | −14% |
| Oct | 6 | 4 of 6 | −6.6% |
| Nov | 5 | 2 of 5 | −2.0% |
| Dec | 5 | 3 of 5 | −6.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry